OpenAI's Sam Altman trusts AI will treat most diseases by 2035

Open AI CEO Sam Altman joins Kara Swisher to discuss a broad range of AI and longevity-related topics including AI's role in the medical field, human health, and even AI CEOs. 0:00 Where does Sam Altman's interest in AI come from? 3:48 What is the goal of Retro Biosciences? 6:33 AI and the medical field 11:03 What can superintelligence teach us? 13:28 Extending human life 20:06 The ethics of AI Stream more of Kara's sharp-witted journey into the science, culture, and business of longevity now on the CNN app: https://www.cnn.com/videos/title-2555467 #AI #Science #News